ATE99328T1 - Polypeptide mit einer aktivitaet des menschlichen beta-andrenergischen rezeptors, einbezogen in die lipolytische antwort, deren nukleinsaeuresequenzen. - Google Patents

Polypeptide mit einer aktivitaet des menschlichen beta-andrenergischen rezeptors, einbezogen in die lipolytische antwort, deren nukleinsaeuresequenzen.

Info

Publication number
ATE99328T1
ATE99328T1 AT90902296T AT90902296T ATE99328T1 AT E99328 T1 ATE99328 T1 AT E99328T1 AT 90902296 T AT90902296 T AT 90902296T AT 90902296 T AT90902296 T AT 90902296T AT E99328 T1 ATE99328 T1 AT E99328T1
Authority
AT
Austria
Prior art keywords
polypeptides
pct
beta
andrenegic
activity
Prior art date
Application number
AT90902296T
Other languages
English (en)
Inventor
Laurent Emorine
Stefano Marullo
Donny Strosberg
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378098&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE99328(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE99328T1 publication Critical patent/ATE99328T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/286—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT90902296T 1989-01-25 1990-01-25 Polypeptide mit einer aktivitaet des menschlichen beta-andrenergischen rezeptors, einbezogen in die lipolytische antwort, deren nukleinsaeuresequenzen. ATE99328T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8900918A FR2642075B1 (fr) 1989-01-25 1989-01-25 Polypeptides ayant une activite de recepteur (beta)-adrenergique chez l'homme, impliques dans la reponse lipolytique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substance active sur ces polypeptides
PCT/FR1990/000054 WO1990008775A1 (fr) 1989-01-25 1990-01-25 POLYPEPTIDES AYANT UNE ACTIVITE DE RECEPTEUR β ADRENERGIQUE CHEZ L'HOMME, IMPLIQUES DANS LA REPONSE LIPOLYTIQUE, ACIDES NUCLEIQUES CODANT POUR CES POLYPEPTIDES ET UTILISATION DE CES POLYPEPTIDES POUR LE CRIBLAGE DE SUBSTANCE ACTIVE SUR CES POLYPEPTIDES

Publications (1)

Publication Number Publication Date
ATE99328T1 true ATE99328T1 (de) 1994-01-15

Family

ID=9378098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90902296T ATE99328T1 (de) 1989-01-25 1990-01-25 Polypeptide mit einer aktivitaet des menschlichen beta-andrenergischen rezeptors, einbezogen in die lipolytische antwort, deren nukleinsaeuresequenzen.

Country Status (10)

Country Link
US (1) US5288607A (de)
EP (1) EP0455682B1 (de)
JP (1) JP3050238B2 (de)
AT (1) ATE99328T1 (de)
CA (1) CA2045658C (de)
DE (1) DE69005620T2 (de)
DK (1) DK0455682T3 (de)
ES (1) ES2062508T3 (de)
FR (1) FR2642075B1 (de)
WO (1) WO1990008775A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274706B1 (en) 1989-01-25 2001-08-14 Centre National De La Recherche Scientifique Intron/exon of the human and mouse beta 3-adrenergic receptor genes
US6635442B1 (en) 1989-01-25 2003-10-21 Centre National De La Recherche Scientific Intron/exon structure of the human and mouse β3-adrenergic receptor genes
US5840836A (en) * 1989-02-17 1998-11-24 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
US6811989B1 (en) * 1989-02-17 2004-11-02 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
US5155218A (en) 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors
US5935925A (en) * 1990-05-08 1999-08-10 Synaptic Pharmaceutical Corporation Methods of treating migraine and compounds useful for such methods
IT1252444B (it) * 1990-09-07 1995-06-16 Enichem Spa Metodo per l'identificazione e/o l'isolamento di geni che codificano per recettori di membrana.
FR2671559B1 (fr) * 1991-01-14 2002-09-27 Ct Nal Rech Scient Sequences codant pour le recepteur beta3-adrenergique murin, leur utilisation comme sondes et pour l'expression de peptides, vecteurs, hotes cellulaires contenant ledit vecteur, et applications desdits peptides.
US5418160A (en) * 1991-11-01 1995-05-23 The United States As Represented By The Secretary Of The Department Of Health And Human Services Cloned cell line expressing rat β3A adrenergic receptor
US5364772A (en) * 1992-07-20 1994-11-15 Wayne State University DNA molecule encoding the β3 -adrenergic receptor
US5455461A (en) * 1992-09-21 1995-10-03 Fujitsu Limited Semiconductor device having reformed pad
EP0600136B1 (de) * 1992-12-01 2002-03-13 Centre National De La Recherche Scientifique Intron/Exon Struktur der Genen von den menschlichen und Maus Beta 3 adrenergischen Rezeptoren
FR2704235B1 (fr) * 1993-04-21 1995-06-23 Vetigen Sarl Séquences nucléotidiques codant pour le récepteur beta3-adrénergique (RAbeta3) bovin et leurs applications.
US5789651A (en) * 1993-05-21 1998-08-04 Martin Marietta Energy Systems, Inc. Isolation and characterization of Agouti: a diabetes/obesity related gene
US5817477A (en) * 1995-06-06 1998-10-06 Human Genome Sciences, Inc. Adrenergic receptor
JPH10510701A (ja) * 1994-08-10 1998-10-20 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド アドレナリンレセプター
EP0791009A4 (de) * 1994-11-07 2003-03-05 Merck & Co Inc Modifizierter neuropeptid-y-rezeptor
US5766851A (en) * 1995-05-19 1998-06-16 The Johns Hopkins University School Of Medicine Susceptibility gene for obesity and type II diabetes mellitus
FR2746813B1 (fr) * 1996-03-26 1998-05-07 Vetigen Sarl Sequences codant pour les recepteurs beta2- et beta3- adrenergiques canins et leurs applications en tant que sondes et pour l'expression de peptides
US5789654A (en) * 1996-05-09 1998-08-04 Beth Israel Hospital Association Transgenic animals deficient in endogenous β3 -adrenergic receptor and uses thereof
WO2001098492A1 (en) * 2000-06-20 2001-12-27 Chugai Seiyaku Kabushiki Kaisha Novel transcription factor having zinc finger domain
JP2004504420A (ja) * 2000-07-17 2004-02-12 ユニベーション・テクノロジーズ・エルエルシー 触媒系及びその重合方法への使用
NZ547178A (en) * 2003-11-20 2008-06-30 Alteragon Pty Ltd Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol
EP1947103A1 (de) 2007-01-22 2008-07-23 4Sc Ag Aryloxypropanolamine, Herstellungsverfahren dafür und Verwendung von Aryloxypropanolaminen als Arzneimittel

Also Published As

Publication number Publication date
JP3050238B2 (ja) 2000-06-12
DK0455682T3 (da) 1994-01-31
CA2045658A1 (fr) 1990-07-26
FR2642075A1 (fr) 1990-07-27
ES2062508T3 (es) 1994-12-16
WO1990008775A1 (fr) 1990-08-09
FR2642075B1 (fr) 1991-04-26
JPH04504354A (ja) 1992-08-06
DE69005620T2 (de) 1994-07-21
DE69005620D1 (de) 1994-02-10
EP0455682A1 (de) 1991-11-13
EP0455682B1 (de) 1993-12-29
CA2045658C (fr) 2000-01-04
US5288607A (en) 1994-02-22

Similar Documents

Publication Publication Date Title
ATE99328T1 (de) Polypeptide mit einer aktivitaet des menschlichen beta-andrenergischen rezeptors, einbezogen in die lipolytische antwort, deren nukleinsaeuresequenzen.
Wells et al. Identification of an autocrine negative growth factor: mouse β-galactoside-binding protein is a cytostatic factor and cell growth regulator
DK150992A (da) Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor
Yoo et al. Conversion of lysine 91 to methionine or glutamic acid in human choriogonadotropin alpha results in the loss of cAMP inducibility.
Campbell Growth-hormone signal transduction
ATE189526T1 (de) Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
KR890701626A (ko) 뇨난포 자극호르몬
EP0149548A3 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
Martens et al. Biosynthesis of pairs of peptides related to melanotropin, corticotropin and endorphin in the pars intermedia of the amphibian pituitary gland
ATE335818T1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
ES2090598T3 (es) Procedimiento de ensayo de proteinas de union de hormonas inmunofuncional mediado por ligando.
Zigman et al. Human G (olf) alpha: complementary deoxyribonucleic acid structure and expression in pancreatic islets and other tissues outside the olfactory neuroepithelium and central nervous system
Williams et al. Control of drinking behavior by means of an operant-conditioning technique
WEIR et al. Isolation of 16,000-dalton parathyroid hormone-like proteins from two animal tumors causing humoral hypercalcemia of malignancy
Csaba et al. Amplification of hormone receptors by neonatal oxytocin and vasopressin treatment
DE69115917D1 (de) Humane gammainterferonantagonisten
Chinery et al. Modulation of epidermal growth factor effects on epithelial ion transport by intestinal trefoil factor
HINTZ The somatomedins
Miller et al. An N-terminal partial sequence of the 13 kDa Pycnopodia helianthoides sperm chemoattractant ‘startrak’possesses sperm-attracting activity
Castro et al. Biosynthesis of corticotrophin-releasing hormone (CRH) in mouse corticotrophic tumour cells expressing the human proCRH gene: intracellular storage and regulated secretion
Hong et al. The β-subunit of human choriogonadotropin interacts with the exodomain of the luteinizing hormone/choriogonadotropin receptor and changes its interaction with the α-subunit
ES2109716T3 (es) Deteccion de proteinas termoestables de carne de rumiantes.
ATE273517T1 (de) Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins
Hymer et al. Growth hormone variants and human exercise
Hoshi et al. Pertussis toxin-sensitive G protein participating in starfish oocyte maturation induced by 1-methyladenine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time